Loading...

Monthly Newsletter

April 2021 Issue


 April 19, 2021

Updates & Announcements

New visiting research scholars guidance

Duke University values collaborations with external researchers and understands that these collaborations are vital to advancing education and research. In order to continue to foster these relationships and collaborations and ensure appropriate disclosure to our sponsors, Duke has developed a new Guidance on Visiting Research Scholars at Duke that provides additional definitions and information on the requirement to register Visiting Research Scholars via the Visiting Scholar REDCap Registry for all Duke schools and departments. A list of Department/ School/Unit Designees for REDCap can be found on the DOSI website. A fillable PDF form is also located on the website to help ensure all necessary information is collected in order to enter the Visiting Research Scholar.

If you have questions or don’t see a designee for your area please contact Pearce Jackson at pearce.jackson@duke.edu.

 

Now is the time to switch to SciENcv!

If you are like many, you have pondered making the switch to SciENcv to generate biosketches and other support, but you haven’t invested the time. Given the new changes that go into effect in May of 2021, now is the time to prioritize the change. SciENcv has been adopted by federal agencies (e.g., NIH and NSF) to streamline development of documents such as biosketches and Other Support. By connecting your NSF or NIH account with a My NCBI, you allow SciENcv to pull information from existing profiles and populate your NSF/NIH biosketch or NSF Other support document. Templates may be saved to produce future documents and update with new information. Help information is available online and from experts at the Medical Center Library. A little time invested now saves you time in the future.

 

Five days in advance of due date allows for internal review

Researchers submitting proposals for external funding should have the application ready, including “near-final science,” five days in advance of the sponsor’s due date. This review policy, which applies to proposals being submitted through ORA and ORS, allows time for adequate review and to ensure compliance with institutional and sponsor requirements. Duke’s goal is to catch any potential issues early enough to communicate back to PIs and allow for smooth submission.

More information about the proposal review process, including what counts as “near-final science” (i.e., what can and cannot change during that five-day period) can be found on the myRESEARCHpath page dedicated to Institutional Proposal Review.

 

How to prevent, manage, and report problems with authorship, ownership, and plagiarism

10% of the research misconduct complaints at Duke University are related to plagiarism, but authorship is also a very common reason for academic disagreements. Duke experts in authorship, plagiarism, copyright and text recycling discussed during DOSI’s most recent town hall common authorship and plagiarism problems, and how to prevent them. Read more on DOSI’s Integrity Insights at dosi.duke.edu.

 

Resources & Tools

New in myRESEARCHpath: Planning research involving apps, websites, and wearables

Early planning of research involving technology such as mobile apps, websites, or wearables is critical for understanding the regulatory, financial, and technical needs of your project. Fortunately, there is guidance available and offices that can help. Access the newly released “Planning research involving apps, websites, and wearables” page in myRESEARCHpath for resources to support these planning efforts.

 

Export Controls and Fundamental Research

Duke makes every effort to utilize exemptions for public domain information and fundamental research so that the bulk of our research activities on campus can operate exempt from most export control regulations. Learn more about fundamental research, contracts, and NDA’s at export.duke.edu.

 

New Project Tracker Tool in myRESEARCHhome

You can now easily track Industry-sponsored clinical trials awaiting institutional approval in myRESEARCHhome. See the approval statuses of the contract from Innovate, budget & calendar from OnCore, and IRB protocol from iRIS all at once. This information can be found in the myPortfolio widget alongside your other research project information. Visit mrh.duke.edu or learn more in the quick reference guide.

 

Institutionally-limited opportunities and nomination process

Limited submission funding opportunities differ from other funding opportunities in that Duke University (including the School of Medicine) is invited to submit a limited number of proposals in response to a specific program. These funding opportunities are sponsored by federal agencies (e.g., NIH, NSF), foundations, and some are even corporation sponsored. Learn more about available opportunities and the nomination process at ocrd.duke.edu.